Corticostriatal signatures of schadenfreude: evidence from Huntington's disease

Sandra Baez1,2,3,4, Mariana Pino5, Mildred Berrío5

  • 1Laboratory of Experimental Psychology and Neuroscience (LPEN), Institute of Cognitive and Translational Neuroscience (INCyT), INECO Foundation, Favaloro University, Buenos Aires, Argentina.

Insights

Patients with Huntington's disease (HD) experience less schadenfreude, a pleasure in others' misfortune. This reduction is linked to brain atrophy in reward and mentalizing regions, impacting social emotions.

Area of Science:

  • Neuroscience
  • Social Psychology
  • Clinical Neurology

Background:

  • Schadenfreude, a complex social emotion, involves reward processing and mentalizing.
  • Huntington's disease (HD) patients show reduced schadenfreude, suggesting striatal degeneration's role.
  • The direct link between HD-related brain atrophy and schadenfreude deficits remains uninvestigated.

Purpose of the Study:

  • To investigate the correlation between grey matter (GM) atrophy in HD patients and their schadenfreude ratings.
  • To compare schadenfreude and envy experiences between HD patients and controls.
  • To identify specific brain regions where atrophy is associated with impaired schadenfreude in HD.

Main Methods:

  • Compared schadenfreude and envy ratings in 20 HD patients and 23 controls using an experimental task.
  • Assessed grey matter (GM) volume differences between the HD patient group and the control group.
  • Correlated regional brain atrophy with schadenfreude impairments in HD patients.

Main Results:

  • HD patients reported significantly lower schadenfreude compared to controls.
  • Envy ratings were comparable between HD patients and controls.
  • Reduced schadenfreude in HD patients correlated with atrophy in the ventral striatum (reward system) and precuneus/superior parietal lobule (mentalizing network).

Conclusions:

  • Striatal and mentalizing network atrophy in HD patients underlies deficits in experiencing schadenfreude.
  • Highlights the interconnectedness of reward processing and socioemotional functions in schadenfreude.
  • Provides novel neural correlates for schadenfreude, implicating specific brain regions in its processing.

Related Concept Videos

Negative and Cognitive Symptoms of Schizophrenia01:30

Negative and Cognitive Symptoms of Schizophrenia

Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
758
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Positive Symptoms of Schizophrenia: Hallucinations and Delusions01:30

Positive Symptoms of Schizophrenia: Hallucinations and Delusions

Schizophrenia is a complex mental health disorder that can manifest with various positive symptoms, including thought, movement, and behavior disorders. These symptoms significantly disrupt cognitive and motor functions, leading to profound effects on an individual's ability to engage with the world.
Thought Disorders
Disorganized and unusual thought processes mark thought disorders in schizophrenia. One key feature is disorganized speech, where an individual's conversation includes...
802
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K